• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology Announces Unaudited Second Quarter 2024 Financial Results

    8/16/24 5:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, Aug. 16, 2024 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2024.

    Second Quarter 2024 Financial Highlights

    • Net revenues were RMB627.2 million (US$86.3 million) in the second quarter of 2024, compared with RMB378.1 million in the same period of 2023.
    • Gross margin was 25.2% in the second quarter of 2024, compared with 26.1% in the same period of 2023.
    • U.S. GAAP net income was RMB134.9 million (US$18.6 million) in the second quarter of 2024, compared with RMB204.7 million in the same period of 2023.
    • Non-GAAP net income[1] was RMB213.1 million (US$29.3 million) in the second quarter of 2024, compared with RMB86.2 million in the same period of 2023.

    "We delivered a strong second quarter performance as revenue continued to increase sequentially, driven by our international business expansion," commented Ms. Ying (Kate) Wang, Co-founder, Chairperson of the Board of Directors, and Chief Executive Officer of RLX Technology. "Our deep exploration of overseas markets and regulations has provided us with valuable insights into the global e-vapor landscape, enabling us to create effective, targeted regional strategies. This year, global regulations are rapidly evolving, with more regulators recognizing e-vapor products as harm-reduction tools for adult smokers. Leveraging our broad expertise in regulatory compliance, we are well-prepared to navigate these changes and ensure a seamless transition for our users and partners. We remain dedicated to product innovation as a key driver of user engagement and market share and are collaborating closely with local partners to introduce compelling offerings. As a trusted e-vapor brand for adult smokers, we will continue to deliver high-quality, compliant products while capitalizing on diverse growth opportunities around the globe."

    Mr. Chao Lu, Chief Financial Officer of RLX Technology, added, "In the second quarter, our net revenues reached RMB627.2 million, a 66% year-over-year increase that underscores our ability to capture growth opportunities in international markets. While our gross margin declined slightly due to an unfavorable shift in our revenue mix, disciplined cost management bolstered our non-GAAP operating profit margins. Looking ahead, we are confident of driving continued improvement in both our top and bottom lines, fueled by ongoing revenue growth from international markets and our relentless focus on operational efficiency. As always, our priority is to deliver sustainable and profitable returns to our shareholders."

    Second Quarter 2024 Financial Results

    Net revenues were RMB627.2 million (US$86.3 million) in the second quarter of 2024, compared with RMB378.1 million in the same period of 2023. The increase was primarily due to our international expansion.

    Gross profit was RMB157.9 million (US$21.7 million) in the second quarter of 2024, compared with RMB98.5 million in the same period of 2023.

    Gross margin was 25.2% in the second quarter of 2024, compared with 26.1% in the same period of 2023. The decrease was primarily due to an unfavorable change in the revenue mix.

    Operating expenses were RMB191.2 million (US$26.3 million) in the second quarter of 2024, compared with RMB47.2 million in the same period of 2023. The increase was primarily due to an increase in share-based compensation expenses, from positive RMB118.5 million in the second quarter of 2023 to RMB78.1 million (US$10.8 million) in the second quarter of 2024. The changes in share-based compensation expenses were primarily due to the changes in the fair value of the share incentive awards that the Company granted to its employees with the fluctuations of the Company's share price.

    Selling expenses were RMB62.2 million (US$8.6 million) in the second quarter of 2024, compared with RMB45.2 million in the same period of 2023, primarily due to an increase in share-based compensation expenses.

    General and administrative expenses were RMB129.0 million (US$17.8 million) in the second quarter of 2024, compared with positive RMB41.4 million in the same period of 2023, primarily due to an increase in share-based compensation expenses.

    Research and development expenses were positive RMB0.04 million (US$0.005 million) in the second quarter of 2024, compared with RMB43.3 million in the same period of 2023, primarily due to a decrease in salaries, welfare benefits and share-based compensation expenses.

    Loss from operations was RMB33.3 million (US$4.6 million) in the second quarter of 2024, compared with income from operations of RMB51.4 million in the same period of 2023.

    Income tax expense was RMB21.4 million (US$2.9 million) in the second quarter of 2024, compared with RMB51.5 million in the same period of 2023.

    U.S. GAAP net income was RMB134.9 million (US$18.6 million) in the second quarter of 2024, compared with RMB204.7 million in the same period of 2023.

    Non-GAAP net income was RMB213.1 million (US$29.3 million) in the second quarter of 2024, compared with RMB86.2 million in the same period of 2023.

    U.S. GAAP basic and diluted net income per American depositary share ("ADS") were RMB0.108 (US$0.015) and RMB0.103 (US$0.014), respectively, in the second quarter of 2024, compared with U.S. GAAP basic and diluted net income per ADS of RMB0.154 and RMB0.150, respectively, in the same period of 2023.

    Non-GAAP basic and diluted net income per ADS[2] were RMB0.171 (US$0.024) and RMB0.164 (US$0.023), respectively, in the second quarter of 2024, compared with non-GAAP basic and diluted net income per ADS of RMB0.064 and RMB0.062, respectively, in the same period of 2023.

    Balance Sheet and Cash Flow

    As of June 30, 2024, the Company had cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, net, long-term bank deposits, net and long-term investment securities, net of RMB14,930.8 million (US$2,054.5 million), compared with RMB14,681.4 million as of March 31, 2024. In the second quarter of 2024, net cash generated from operating activities was RMB196.8 million (US$27.1 million).

    Conference Call

    The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on August 16, 2024 (8:00 PM Beijing/Hong Kong Time on August 16, 2024).

    Dial-in details for the earnings conference call are as follows:

    United States (toll-free):

    +1-888-317-6003

    International:

    +1-412-317-6061

    Hong Kong, China (toll-free):

    +800-963-976

    Hong Kong, China:

    +852-5808-1995

    Mainland China:

    400-120-6115

    Participant Code:

    3613850

    Participants should dial in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.

    Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.

    A replay of the conference call will be accessible approximately two hours after the conclusion of the call until August 23, 2024, by dialing the following telephone numbers:

    United States:

    +1-877-344-7529

    International:

    +1-412-317-0088

    Replay Access Code:

    9416265

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Non-GAAP Financial Measures

    The Company uses non-GAAP net income and non-GAAP basic and diluted net income per ADS, each a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. Non-GAAP net income represents net income excluding share-based compensation expenses. Non-GAAP basic and diluted net income per ADS is computed using non-GAAP net income attributable to RLX Technology Inc. and the same number of ADSs used in U.S. GAAP basic and diluted net income per ADS calculation.

    The Company presents these non-GAAP financial measures because they are used by the management to evaluate its operating performance and formulate business plans. The Company believes that they help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that are included in net income. The Company also believes that the use of the non-GAAP measures facilitates investors' assessment of its operating performance, as they could provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects and allows for greater visibility with respect to key metrics used by the management in its financial and operational decision making.

    The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. They should not be considered in isolation or construed as an alternative to net income, basic and diluted net income per ADS or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review its historical non-GAAP financial measures to the most directly comparable U.S. GAAP measures. The non-GAAP financial measures here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. The Company encourages investors and others to review its financial information in its entirety and not rely on any single financial measure.

    For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliation of GAAP and non-GAAP Results" set forth at the end of this press release.

    Exchange Rate Information

    This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB 7.2672 to US$1.00, the exchange rate on June 28, 2024, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" and similar statements. Among other things, quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward- looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; trends and competition in global e-vapor market; changes in its revenues and certain cost or expense items; governmental policies, laws and regulations across various jurisdictions relating to the Company's industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is current as of the date of this press release, and the Company does not undertake any obligation to update such information, except as required under applicable law.

    For more information, please contact:

    In China:

    RLX Technology Inc.

    Head of Capital Markets

    Sam Tsang

    Email: [email protected]

    Piacente Financial Communications

    Jenny Cai

    Tel: +86-10-6508-0677

    Email: [email protected]

    In the United States:

    Piacente Financial Communications

    Brandi Piacente

    Tel: +1-212-481-2050

    Email: [email protected]

    [1] Non-GAAP net income is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    [2] Non-GAAP basic and diluted net income per ADS is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (All amounts in thousands)











    As of



    December 31,

    June 30,

    June 30,



    2023

    2024

    2024



    RMB

    RMB

    US$

    ASSETS







    Current assets:







    Cash and cash equivalents

    2,390,298

    3,076,781

    423,379

    Restricted cash

    29,760

    61,908

    8,519

    Short-term bank deposits, net

    2,631,256

    2,615,677

    359,929

    Receivables from online payment platforms

    6,893

    5,619

    773

    Short-term investments, net

    3,093,133

    2,604,414

    358,379

    Accounts and notes receivable, net

    60,482

    114,428

    15,746

    Inventories

    144,850

    84,306

    11,601

    Amounts due from related parties

    118,736

    196,791

    27,079

    Prepayments and other current assets, net

    508,435

    709,991

    97,698

    Total current assets

    8,983,843

    9,469,915

    1,303,103

    Non-current assets:







    Property, equipment and leasehold improvement, net

    77,358

    63,192

    8,696

    Intangible assets, net

    69,778

    60,215

    8,286

    Long-term investments, net

    8,000

    8,000

    1,101

    Deferred tax assets, net

    58,263

    58,264

    8,017

    Right-of-use assets, net

    52,562

    39,604

    5,450

    Long-term bank deposits, net

    1,757,804

    876,340

    120,588

    Long-term investment securities, net

    5,236,109

    5,695,667

    783,750

    Goodwill

    66,506

    62,606

    8,615

    Other non-current assets, net

    4,874

    6,499

    894

    Total non-current assets

    7,331,254

    6,870,387

    945,397

    Total assets

    16,315,097

    16,340,302

    2,248,500









    LIABILITIES AND SHAREHOLDERS' EQUITY







    Current liabilities:







    Accounts and notes payable

    266,426

    323,811

    44,558

    Contract liabilities

    49,586

    56,908

    7,831

    Salary and welfare benefits payable

    39,256

    60,048

    8,263

    Taxes payable

    77,164

    79,197

    10,898

    Accrued expenses and other current liabilities

    103,996

    99,440

    13,683

    Amounts due to related parties

    101,927

    10,984

    1,511

    Dividend payable

    881

    -

    -

    Lease liabilities - current portion

    29,435

    28,202

    3,881

    Total current liabilities

    668,671

    658,590

    90,625









    Non-current liabilities:







    Deferred tax liabilities

    23,591

    21,790

    2,998

    Lease liabilities - non-current portion

    24,419

    13,124

    1,808

    Total non-current liabilities

    48,010

    34,914

    4,806

    Total liabilities

    716,681

    693,504

    95,431

















    Shareholders' Equity:







    Total RLX Technology Inc. shareholders' equity

    15,609,393

    15,654,233

    2,154,092

    Noncontrolling interests

    (10,977)

    (7,435)

    (1,023)

    Total shareholders' equity

    15,598,416

    15,646,798

    2,153,069









    Total liabilities and shareholders' equity

    16,315,097

    16,340,302

    2,248,500

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

    (All amounts in thousands, except for share and per share data)





















    For the three months ended



    For the six months ended



    June 30,

    March 31,

    June 30,

    June 30,



    June 30,

    June 30,

    June 30,



    2023

    (As adjusted) (a)

    2024

    2024

    2024



    2023

    (As adjusted) (a)

    2024

    2024



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



















    Net revenues

    378,123

    551,623

    627,176

    86,302



    567,000

    1,178,799

    162,208

    Cost of revenues

    (171,733)

    (327,610)

    (400,712)

    (55,140)



    (250,426)

    (728,322)

    (100,220)

    Excise tax on products

    (107,853)

    (81,240)

    (68,602)

    (9,440)



    (172,311)

    (149,842)

    (20,619)

    Gross profit

    98,537

    142,773

    157,862

    21,722



    144,263

    300,635

    41,369



















    Operating expenses:

















    Selling expenses

    (45,226)

    (52,887)

    (62,235)

    (8,564)



    (130,987)

    (115,122)

    (15,841)

    General and administrative expenses

    41,368

    (109,954)

    (128,997)

    (17,751)



    (215,136)

    (238,951)

    (32,881)

    Research and development expenses

    (43,317)

    (31,540)

    40

    5



    (119,999)

    (31,500)

    (4,335)

    Total operating expenses

    (47,175)

    (194,381)

    (191,192)

    (26,310)



    (466,122)

    (385,573)

    (53,057)



















    Income/(loss) from operations

    51,362

    (51,608)

    (33,330)

    (4,588)



    (321,859)

    (84,938)

    (11,688)



















    Other income:

















    Interest income, net

    162,888

    158,858

    154,207

    21,220



    311,691

    313,065

    43,079

    Investment income  

    20,588

    12,776

    12,718

    1,750



    41,973

    25,494

    3,508

    Others, net

    21,380

    28,943

    22,739

    3,129



    150,537

    51,682

    7,112

    Income before income tax

    256,218

    148,969

    156,334

    21,511



    182,342

    305,303

    42,011

    Income tax expense  

    (51,502)

    (16,344)

    (21,389)

    (2,943)



    (33,931)

    (37,733)

    (5,192)

    Net income

    204,716

    132,625

    134,945

    18,568



    148,411

    267,570

    36,819

    Less: net income attributable to noncontrolling interests

    1,929

    717

    2,631

    362



    2,590

    3,348

    461

    Net income attributable to RLX Technology Inc.

    202,787

    131,908

    132,314

    18,206



    145,821

    264,222

    36,358

    Other comprehensive income:

















    Foreign currency translation adjustments

    563,078

    12,706

    44,174

    6,078



    414,982

    56,880

    7,827

    Unrealized income/(loss) on long-term investment

        securities

    5,539

    (13)

    705

    97



    8,412

    692

    95

    Total other comprehensive income

    568,617

    12,693

    44,879

    6,175



    423,394

    57,572

    7,922

    Total comprehensive income

    773,333

    145,318

    179,824

    24,743



    571,805

    325,142

    44,741

    Less: total comprehensive income attributable to

        noncontrolling interests

    1,929

    730

    2,618

    360



    2,590

    3,348

    461

    Total comprehensive income attributable to RLX

        Technology Inc.

    771,404

    144,588

    177,206

    24,383



    569,215

    321,794

    44,280



















    Net income per ordinary share/ADS 

















     Basic

    0.154

    0.106

    0.108

    0.015



    0.111

    0.213

    0.029

     Diluted

    0.150

    0.101

    0.103

    0.014



    0.108

    0.205

    0.028



















    Weighted average number of ordinary shares/ADSs

















    Basic

    1,318,628,588

    1,249,317,641

    1,228,869,526

    1,228,869,526



    1,317,718,705

    1,239,093,583

    1,239,093,583

    Diluted

    1,353,296,802

    1,301,431,007

    1,284,388,803

    1,284,388,803



    1,348,021,483

    1,290,853,297

    1,290,853,297



    Note (a): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted

    the above comparative unaudited condensed consolidated statements of comprehensive income in the prior quarter.

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (All amounts in thousands, except for share and per share data)













    For the three months ended



    For the six months ended



    June 30,

    March 31,

    June 30,

    June 30,



    June 30,

    June 30,

    June 30,



    2023

    (As adjusted) (b)

    2024

    2024

    2024



    2023

    (As adjusted) (b)

    2024

    2024



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    Net income

    204,716

    132,625

    134,945

    18,568



    148,411

    267,570

    36,819

    Add: share-based compensation expenses

















           Selling expenses

    (15,338)

    4,603

    9,172

    1,262



    8,617

    13,775

    1,895

           General and administrative expenses

    (90,923)

    66,414

    93,026

    12,801



    110,420

    159,440

    21,940

           Research and development expenses

    (12,229)

    3,881

    (24,074)

    (3,313)



    2,425

    (20,193)

    (2,779)

    Non-GAAP net income

    86,226

    207,523

    213,069

    29,318



    269,873

    420,592

    57,875



















    Net income attributable to RLX Technology Inc.

    202,787

    131,908

    132,314

    18,206



    145,821

    264,222

    36,358

    Add: share-based compensation expenses

    (118,490)

    74,898

    78,124

    10,750



    121,462

    153,022

    21,056

    Non-GAAP net income attributable to RLX

        Technology Inc.

    84,297

    206,806

    210,438

    28,956



    267,283

    417,244

    57,414



















    Non-GAAP net income per ordinary share/ADS

















    - Basic

    0.064

    0.166

    0.171

    0.024



    0.203

    0.337

    0.046

    - Diluted

    0.062

    0.159

    0.164

    0.023



    0.198

    0.323

    0.044

    Weighted average number of ordinary shares/ADSs

















    - Basic

    1,318,628,588

    1,249,317,641

    1,228,869,526

    1,228,869,526



    1,317,718,705

    1,239,093,583

    1,239,093,583

    - Diluted

    1,353,296,802

    1,301,431,007

    1,284,388,803

    1,284,388,803



    1,348,021,483

    1,290,853,297

    1,290,853,297



    Note (b): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted

    the above unaudited reconciliation of GAAP and Non-GAAP results in the prior quarter.

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (All amounts in thousands)





















    For the three months ended



    For the six months ended



    June 30,

    March 31,

    June 30,

    June 30,



    June 30,

    June 30,

    June 30,



    2023

    (As adjusted) (c)

    2024

    2024

    2024



    2023

    (As adjusted) (c)

    2024

    2024



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    Net cash generated from/(used in) operating

        activities

    41,339

    4,020

    196,764

    27,076



    (189,347)

    200,784

    27,629

    Net cash generated from investing activities

    431,683

    420,665

    557,132

    76,664



    813,637

    977,797

    134,549

    Net cash used in financing activities

    (199,080)

    (472,885)

    -

    -



    (194,734)

    (472,885)

    (65,071)

    Effect of foreign exchange rate changes on cash,

        cash equivalents and restricted cash

    48,393

    2,903

    10,032

    1,380



    58,802

    12,935

    1,780

    Net increase/(decrease) in cash and cash

        equivalents and restricted cash 

    322,335

    (45,297)

    763,928

    105,120



    488,358

    718,631

    98,887

    Cash, cash equivalents and restricted cash at

        the beginning of the period

    1,455,109

    2,420,058

    2,374,761

    326,778



    1,289,086

    2,420,058

    333,011

    Cash, cash equivalents and restricted cash at

        the end of the period

    1,777,444

    2,374,761

    3,138,689

    431,898



    1,777,444

    3,138,689

    431,898



















    Note (c): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted

    the above comparative unaudited condensed consolidated statements of cash flows in the prior quarter.

     

    Cision View original content:https://www.prnewswire.com/news-releases/rlx-technology-announces-unaudited-second-quarter-2024-financial-results-302224158.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Financials

    Live finance-specific insights

    See more
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

      SHENZHEN, China, March 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenues were RMB813.5 million (US$111.4 million) in the fourth quarter of 2024, compared with RMB520.5 million in the same period of 2023.Gross margin was 27.0% in the fourth quarter of 2024, compared with 23.7% in the same period of 2023.U.S. GAAP net income was RMB127.4 million (US$17.5 million) in the fourth quarter of 2024, compared with RMB216.0 million in the same period

      3/14/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on March 14, 2025 - SHENZHEN, China, March 3, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before the U.S. markets open on Friday, March 14, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 14, 2025 (8:00 PM Beijing/Hong Kong Time on March 14, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412

      3/3/25 10:30:00 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Files 2024 Annual Report on Form 20-F

      SHENZHEN, China, April 17, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC") on April 17, 2025. The annual report on Form 20-F can be accessed on the SEC's website at https://www.sec.gov and on the Company's investor relations website at https://ir.relxtech.com. The Company will provide a hard copy of its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. About RLX Technology Inc. RLX Techno

      4/17/25 8:00:00 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

      SHENZHEN, China, March 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenues were RMB813.5 million (US$111.4 million) in the fourth quarter of 2024, compared with RMB520.5 million in the same period of 2023.Gross margin was 27.0% in the fourth quarter of 2024, compared with 23.7% in the same period of 2023.U.S. GAAP net income was RMB127.4 million (US$17.5 million) in the fourth quarter of 2024, compared with RMB216.0 million in the same period

      3/14/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/7/24 6:06:29 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/6/24 4:01:28 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/14/23 6:01:42 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $RLX
    SEC Filings

    See more
    • RLX Technology downgraded by Citigroup with a new price target

      Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

      3/17/25 7:42:34 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • UBS initiated coverage on RLX Technology with a new price target

      UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

      8/8/23 9:12:45 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by RLX Technology Inc.

      20-F - RLX Technology Inc. (0001828365) (Filer)

      4/17/25 4:01:47 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      3/14/25 6:10:16 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      11/15/24 4:01:25 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care